Analysis reportAll specifications met
GHK-Cu + KPV 60mg
Peptide Stock ref. PSV-2610-CK60-01
Purity99.87%HILIC-CAD + RP-HPLC 214 nm, per component
Content per vial64.5 mg107.5% of 60 mg label claim
IdentityConfirmedHILIC-ESI-MS (GHK-Cu) + LC-MS (ESI+)
Test results
| Test | Specification | Result | Outcome |
|---|---|---|---|
| Identity (LC-MS): GHK-Cu | Within ±1 Da of 402.92 Da | 402.838 Da | Pass |
| Identity (LC-MS): KPV | Within ±1 Da of 342.44 Da | 342.444 Da | Pass |
| Purity (RP-HPLC 214 nm): GHK-Cu | ≥ 99.25% | 99.8% | Pass |
| Purity (RP-HPLC 214 nm): KPV | ≥ 99.25% | 99.93% | Pass |
| Content: GHK-Cu | 45–55 mg | 53.94 mg | Pass |
| Content: KPV | 9–11 mg | 10.56 mg | Pass |
| Net peptide content | GHK-Cu 50 mg + KPV 10 mg | 64.5 mg (107.5% of claim) | Pass |
| Sterility (rapid PCR) | No microbial DNA detected | Not detected | Pass |
About this report
- Sample received by the lab 6 October 2026; report issued 11 October 2026.
- 1 vial tested.
- Appearance as received: lyophilised powder, translucent pink contents.
- Results relate to the sample tested. For laboratory research use only.